Previous studies have reported ENO1 overexpression in several cancers, including breast [16], [17], neck, lung [18], prostate [19], and gastric cancer, where it is closely linked with cancer progression and poor patient prognosis [20]. The gene discussed is ENO1; the disease is cancer.